መነሻ532523 • BOM
add
Biocon Ltd
የቀዳሚ መዝጊያ
₹323.15
የቀን ክልል
₹322.45 - ₹332.30
የዓመት ክልል
₹231.35 - ₹395.65
የገበያው አጠቃላይ ዋጋ
396.60 ቢ INR
አማካይ መጠን
170.80 ሺ
የዋጋ/ገቢ ምጥጥን
27.55
የትርፍ ክፍያ
0.15%
ዋና ልውውጥ
NSE
የገበያ ዜና
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(INR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ገቢ | 35.90 ቢ | 3.70% |
የሥራ ወጪ | 21.42 ቢ | 8.03% |
የተጣራ ገቢ | -160.00 ሚ | -112.74% |
የተጣራ የትርፍ ክልል | -0.45 | -112.40% |
ገቢ በሼር | -0.19 | -115.53% |
EBITDA | 6.78 ቢ | -6.58% |
ውጤታማ የግብር ተመን | 72.46% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(INR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 26.50 ቢ | -30.00% |
አጠቃላይ ንብረቶች | 571.28 ቢ | 4.67% |
አጠቃላይ ተጠያቂነቶች | 304.08 ቢ | 0.36% |
አጠቃላይ እሴት | 267.20 ቢ | — |
የሼሮቹ ብዛት | 1.23 ቢ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 1.89 | — |
የእሴቶች ተመላሽ | — | — |
የካፒታል ተመላሽ | 1.56% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(INR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
የተጣራ ገቢ | -160.00 ሚ | -112.74% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | — | — |
ገንዘብ ከኢንቨስትመንት | — | — |
ገንዘብ ከፋይናንስ | — | — |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | — | — |
ነፃ የገንዘብ ፍሰት | — | — |
ስለ
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
1978
ዋና መሥሪያ ቤት
ድህረገፅ
ሠራተኞች
16,315